Literature DB >> 32914583

Prophylactic anticoagulation of individuals with Proteus syndrome and COVID-19.

Christopher A Ours1, Leslie G Biesecker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32914583      PMCID： PMC7942975          DOI： 10.1002/ajmg.a.61861

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN： 1552-4825            Impact factor:   2.578


× No keyword cloud information.
  15 in total

1.  Proteus syndrome and sudden cardiac arrest; Beware of pulmonary embolism!

Authors:  Lila Papadimitriou; Chris S G Kavalieratos
Journal:  Resuscitation       Date:  2002-09       Impact factor: 5.262

2.  Characterization of thrombosis in patients with Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay N Lozier; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2017-06-19       Impact factor: 2.802

3.  Sudden death caused by pulmonary thromboembolism in Proteus syndrome.

Authors:  A M Slavotinek; S J Vacha; K F Peters; L G Biesecker
Journal:  Clin Genet       Date:  2000-11       Impact factor: 4.438

4.  Quantifying survival in patients with Proteus syndrome.

Authors:  Julie C Sapp; Lian Hu; Jean Zhao; Ashlyn Gruber; Brian Schwartz; Dora Ferrari; Leslie G Biesecker Md
Journal:  Genet Med       Date:  2017-06-29       Impact factor: 8.822

Review 5.  Prevention of Hospital-Acquired Venous Thromboembolism in Children: A Review of Published Guidelines.

Authors:  E Vincent S Faustino; Leslie J Raffini
Journal:  Front Pediatr       Date:  2017-01-26       Impact factor: 3.418

6.  Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.

Authors:  F A Klok; M J H A Kruip; N J M van der Meer; M S Arbous; D Gommers; K M Kant; F H J Kaptein; J van Paassen; M A M Stals; M V Huisman; H Endeman
Journal:  Thromb Res       Date:  2020-04-30       Impact factor: 3.944

7.  Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay Lozier; Neal Oden; Anjali Taneja; Jasmine Burton-Akright; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-09-06       Impact factor: 3.359

8.  Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.

Authors:  Alex C Spyropoulos; Jerrold H Levy; Walter Ageno; Jean Marie Connors; Beverley J Hunt; Toshiaki Iba; Marcel Levi; Charles Marc Samama; Jecko Thachil; Dimitrios Giannis; James D Douketis
Journal:  J Thromb Haemost       Date:  2020-08       Impact factor: 16.036

9.  COVID-19 anticoagulation recommendations in children.

Authors:  Michele Loi; Brian Branchford; John Kim; Chelsea Self; Rachelle Nuss
Journal:  Pediatr Blood Cancer       Date:  2020-06-18       Impact factor: 3.838

10.  COVID-19 and its implications for thrombosis and anticoagulation.

Authors:  Jean M Connors; Jerrold H Levy
Journal:  Blood       Date:  2020-06-04       Impact factor: 25.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.